EC considers innovation and research goals in strategy relaunch:
This article was originally published in Clinica
Promoting innovation and sustainability is one of the main goals enshrined in the proposed relaunch of the European Commission's Lisbon Strategy, which aims to improve the competitiveness of the EU economy. The original Strategy had lost momentum and a draft internal Commission document has called for a refocus and relaunch along more targeted lines. The Commission's competitiveness group, which drafted the report, proposes that the strategy should be repositioned around 10 central policy areas which include, as well as innovation and sustainability, more and better research and development, completing the internal market and creating conditions for a strong European base.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.